Susquehanna International Group, LLP Adicet Bio, Inc. Put Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 15, 2024
BUY
$1.21 - $2.4 $7,502 - $14,880
6,200 Added 33.88%
24,500 $29,000
Q1 2024

May 07, 2024
BUY
$1.76 - $3.45 $32,208 - $63,135
18,300 New
18,300 $43,000
Q2 2023

Aug 11, 2023
SELL
$2.13 - $7.13 $426 - $1,426
-200 Reduced 1.83%
10,700 $26,000
Q1 2023

May 16, 2023
BUY
$5.52 - $9.23 $60,167 - $100,607
10,900 New
10,900 $62,000
Q3 2022

Nov 14, 2022
BUY
$13.43 - $18.74 $757,452 - $1.06 Million
56,400 Added 213.64%
82,800 $1.18 Million

Others Institutions Holding ACET

# of Institutions
72
Shares Held
59.2M
Call Options Held
4.2K
Put Options Held
6.7K
View Full List

About Adicet Bio, Inc.

ACET Quotes by TradingView
  • Ticker ACET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,030,800
  • Market Cap $38M
  • Description
  • Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...
More about ACET
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email